QNRX NASDAQ
Quoin Pharmaceuticals, Ltd.
1W: -30.5%
1M: -33.7%
3M: -2.8%
YTD: -68.2%
1Y: -38.2%
3Y: -97.0%
5Y: -100.0%
$4.47
-0.25 (-5.30%)
Weekly Expected Move ±11.0%
$3
$4
$4
$5
$5
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2023-09-13
Earliest Filing
2023-09-13
Latest Filing
licensee: 1
Counterparties (Filed by QNRX)
1 relationshipsCompanies named in QNRX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Farma Mondo SA | — | licensee | Exclusive license and distribution agreement for pharmaceutical product QRX003 in Singapore | 2023-09-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-22 | Regulation FD; Other Events; Exhibits | View | |
| 2026-09-10 | Regulation FD; Other Events; Exhibits | View | |
| 2026-08-28 | Material Agreement; Unregistered Equity Sales; Regulation FD; Other Events; Exhibits | Agreement | View |
| 2026-08-20 | Officer/Director Change; Shareholder Vote; Other Events | View | |
| 2026-08-14 | Earnings Release; Exhibits | View | |
| 2026-06-23 | Regulation FD; Other Events; Exhibits | View | |
| 2026-06-04 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-03-11 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-20 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-12 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-21 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-15 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-08-27 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-21 | Material Modification to Rights of Security Holders; Departure/Election of Directors; Appointment of | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-08 | Departure/Election of Directors; Appointment of Officers | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR